atumelnant (CRN04894)
CRN04894-09
Phase 2 small_molecule active
Quick answer
atumelnant (CRN04894) for Congenital Adrenal Hyperplasia is a Phase 2 program (small_molecule) at Crinetics Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Crinetics Pharmaceuticals
- Indication
- Congenital Adrenal Hyperplasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active